Magnetic resonance imaging and spectroscopy in late-onset GM2-gangliosidosis-Reference-Cited by-同舟云学术

Magnetic resonance imaging and spectroscopy in late-onset GM2-gangliosidosis

Published:2021-08 Issue:4 Volume:133 Page:386-396
ISSN:1096-7192
Container-title:Molecular Genetics and Metabolism
language:en
Short-container-title:Molecular Genetics and Metabolism

Author:

Rowe Olivia E.,Rangaprakash D.,Weerasekera Akila,Godbole Neha,Haxton Elizabeth,James Peter F.,Stephen Christopher D.,Barry Robert L.,Eichler Florian S.,Ratai Eva-Maria

Funder

NIH

Publisher

Elsevier BV

Subject

Endocrinology,Genetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism

Reference57 articles.

1. The GM2 Gangliosidoses;Gravel,2014

2. Prevalence of lysosomal storage disorders;Meikle;J. Am. Med. Assoc.,1999

3. Natural history of adult patients with GM2 Gangliosidosis;Masingue;Ann. Neurol.,2020

4. Progressive cerebella ataxia, proximal neurogenic weakness and ocular motor disturbances: hexosaminidase a deficiency with late clinical onset in four siblings;Hund;J. Neurol. Sci.,1997

5. Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases;Willner;Neurology,1981

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidoses;Molecular Genetics and Metabolism;2024-07

2. Clinical, Imaging, Genetic, and Disease Course Characteristics in Patients With GM2 Gangliosidosis;Neurology;2024-01-09

3. Quantitative brain morphometry identifies cerebellar, cortical, and subcortical gray and white matter atrophy in late‐onset Tay‐Sachs disease;Journal of Inherited Metabolic Disease;2023-12-19

4. Clinical and imaging predictors of late‐onset GM2 gangliosidosis: A scoping review;Annals of Clinical and Translational Neurology;2023-11-27

5. Meta-analysis and open-source database for in vivo brain Magnetic Resonance spectroscopy in health and disease;Analytical Biochemistry;2023-09